GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lophos Holdings Inc (XCNQ:MESC) » Definitions » Notes Receivable

Lophos Holdings (XCNQ:MESC) Notes Receivable : C$0.00 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Lophos Holdings Notes Receivable?

Lophos Holdings's Notes Receivable for the quarter that ended in Mar. 2024 was C$0.00 Mil.


Lophos Holdings Notes Receivable Historical Data

The historical data trend for Lophos Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lophos Holdings Notes Receivable Chart

Lophos Holdings Annual Data
Trend Mar22 Mar23 Mar24
Notes Receivable
- - -

Lophos Holdings Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Notes Receivable Get a 7-Day Free Trial Premium Member Only - - - - -

Lophos Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Lophos Holdings Notes Receivable Related Terms

Thank you for viewing the detailed overview of Lophos Holdings's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Lophos Holdings Business Description

Traded in Other Exchanges
N/A
Address
1111 Melville Street, Suite 620, Vancouver, BC, CAN, V6E 3V6
Website
Lophos Holdings Inc is engaged in the y is the cultivation of peyote and the manufacture of Lophophora compounds, including Mescaline, as well as formulation of novel Lophophora-based compounds.
Executives
John Ioannis Karagiannidis Director
Evan Stawnyczy Director

Lophos Holdings Headlines

No Headlines